A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel

Clinical trial NCT05796362 · COMPLETED

Trial details

NCT number: NCT05796362
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infectious Disease Drug Effect Clinical Infection

Start date: 2024-08-08
Primary completion: 2025-11-25
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.